Clairvest Reports Strong Second Quarter Results and Completes CEP III Fund
News related to:Clairvest Group Inc · 2 min read
TORONTO, Nov. 11, 2026 /CourierPR/ -- Clairvest Group Inc., a leading private equity management firm, reported strong financial results for its fiscal 2027 second quarter and six months ended September 30, 2026. The company's book value stood at $1.356 billion or $101.35 per share, up 2.1% from $1.328 billion or $99.26 per share as of June 30, 2026. Net income for the quarter was $27.8 million, or $2.08 per share, driven by a net increase in the valuation of Clairvest’s private equity investment portfolio. For the six months, net income amounted to $76.2 million, or $5.69 per share, further bolstered by the same positive portfolio valuation.
The release highlights the successful conclusion of Clairvest Equity Partners III (CEP III), which concluded with a top quartile final return of 2.5 times net for third-party investors. This fund's successful conclusion marks an important achievement for Clairvest. During the quarter, Clairvest and CEP VII made two new investments totaling $73 million, with Clairvest’s share amounting to $18 million. These investments were in the food and beverage domain and the medical practice management sector, areas where Clairvest has prior investments and expertise. Since the commencement of its investment program in 2024, CEP VII has made eight investments, currently at 35% invested.
Clairvest’s book value as of September 30, 2026, was $1.356 billion, or $101.35 per share. The company purchased and cancelled 2,800 common shares at an average price of $78.27 per share, incurring a total cost of $0.2 million. Cash, cash equivalents, and temporary investments, excluding marketable securities, stood at $180 million. Additionally, the company’s acquisition entities held $114 million in cash, cash equivalents, and temporary investments, bringing the total available cash to $294 million. This represented 22% of the company’s book value, or approximately $22.01 per share.
During the quarter, CEP III received the remaining escrow proceeds from the sale of its final investment, and the fund was formally dissolved on September 30, 2026. The completion of CEP III is a meaningful milestone for Clairvest. The fund delivered a top quartile return of 2.5 times net for our investors, a result that reflects the strength of our partnerships with the entrepreneurs we backed and our commitment to seeing every investment through to the end, said Ken Rotman, CEO of Clairvest. At the same time, we continued to build out the CEP VII portfolio with two new investments this quarter, in food and beverage and medical practice management. With eight investments completed and an active pipeline of opportunities in diligence, we expect to substantially complete the CEP VII investment program in 2027, building a high-quality portfolio of businesses.
Clairvest’s second quarter fiscal 2027 financial statements and MD&A are available on the SEDAR website at www.sedarplus.ca and the Clairvest website at www.clairvest.com. The company’s mission is to partner with entrepreneurs to help them build strategically significant businesses. Founded in 1987 by a group of successful Canadian entrepreneurs, Clairvest is a top-performing private equity management firm with over CAD $4.7 billion of capital under management. Under the current management team, Clairvest has initiated investments in 74 different platform companies and generated top quartile performance over an extended period.